{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:16:05Z","timestamp":1769854565312,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1124\/jpet.112.195156","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T03:44:27Z","timestamp":1339213467000},"page":"761-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Serotonin 2C Receptor Antagonist SB 242084 Exhibits Abuse-Related Effects Typical of Stimulants in Squirrel Monkeys"],"prefix":"10.1016","volume":"342","author":[{"given":"Daniel F.","family":"Manvich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather L.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard L.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.195156_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.112.195156_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/syn.20109","article-title":"Modulation of dopamine release by striatal 5-HT2C receptors","volume":"55","author":"Alex","year":"2005","journal-title":"Synapse"},{"key":"10.1124\/jpet.112.195156_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000191473","article-title":"Effects of histamine H3 receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys","volume":"83","author":"Banks","year":"2009","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.112.195156_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pbb.2009.08.011","article-title":"Interactions between the mGluR2\/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys","volume":"94","author":"Bauzo","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.112.195156_bib5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1080\/10826080500294924","article-title":"Pharmacotherapy of comorbid mood, anxiety, and substance use disorders","volume":"40","author":"Brady","year":"2005","journal-title":"Subst Use Misuse"},{"key":"10.1124\/jpet.112.195156_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.112.195156_bib7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biopsych.2006.11.023","article-title":"Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT2C receptor antagonist","volume":"62","author":"Burghardt","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.112.195156_bib8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.npp.1300474","article-title":"Inactivation of 5-HT2C receptors potentiates consequences of serotonin reuptake blockade","volume":"29","author":"Cremers","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.112.195156_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002130050054","article-title":"Cocaine-induced changes in extracellular dopamine determined by microdialysis in awake squirrel monkeys","volume":"148","author":"Czoty","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.112.195156_bib10","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De Deurwaerd\u00e8re","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.112.195156_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1177-9","article-title":"S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models","volume":"199","author":"Dekeyne","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.112.195156_bib12","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.112.195156_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0306-4522(98)00655-1","article-title":"Selective blockade of serotonin-2C\/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study","volume":"91","author":"Di Giovanni","year":"1999","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.112.195156_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2","article-title":"Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C\/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study","volume":"35","author":"Di Giovanni","year":"2000","journal-title":"Synapse"},{"key":"10.1124\/jpet.112.195156_bib15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","article-title":"SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system","volume":"38","author":"Di Matteo","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.112.195156_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00213-009-1545-0","article-title":"Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates","volume":"205","author":"Fantegrossi","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.112.195156_bib17","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.104.068841","article-title":"Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses","volume":"310","author":"Filip","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.195156_bib18","first-page":"576","article-title":"Differential effects of the 5-HT2A receptor antagonist M100907 and the 5-HT2C receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding","volume":"27","author":"Fletcher","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.112.195156_bib19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00213-006-0453-9","article-title":"The effects of the 5-HT2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists","volume":"187","author":"Fletcher","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.112.195156_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pbb.2005.01.004","article-title":"Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys","volume":"80","author":"Ginsburg","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.112.195156_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","article-title":"Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat","volume":"36","author":"Gobert","year":"2000","journal-title":"Synapse"},{"key":"10.1124\/jpet.112.195156_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2006.09.042","article-title":"Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone","volume":"553","author":"Harada","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.195156_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neubiorev.2005.06.007","article-title":"Serotonergic modulation of the limbic system","volume":"30","author":"Hensler","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.112.195156_bib24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0022-3565(25)12217-9","article-title":"Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey","volume":"275","author":"Howell","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.195156_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.112.195156_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0091-3057(01)00745-6","article-title":"The medical benefit of 5-HT research","volume":"71","author":"Jones","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.112.195156_bib27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/jpet.105.086413","volume":"315","author":"Kantor","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.195156_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/syn.20135","article-title":"Changes in extracellular dopamine during cocaine self-administration in squirrel monkeys","volume":"56","author":"Kimmel","year":"2005","journal-title":"Synapse"},{"key":"10.1124\/jpet.112.195156_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.pbb.2009.09.007","article-title":"Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey","volume":"94","author":"Kimmel","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.112.195156_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pbb.2006.12.006","article-title":"Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys","volume":"86","author":"Kimmel","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.112.195156_bib31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1517\/13543776.2010.518956","article-title":"5-HT2C receptor modulators: a patent survey","volume":"20","author":"Lee","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/jpet.112.195156_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/syn.1095","article-title":"Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with [3H]mesulergine binding sites and choline acetyltransferase mRNA","volume":"42","author":"L\u00f3pez-Gim\u00e9nez","year":"2001","journal-title":"Synapse"},{"key":"10.1124\/jpet.112.195156_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/jpet.106.106989","article-title":"WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity","volume":"320","author":"Marquis","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.195156_bib34","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1038\/sj.npp.1395370","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.112.195156_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09540260801889211","article-title":"SSRI adverse events: how to monitor and manage","volume":"20","author":"Murphy","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"10.1124\/jpet.112.195156_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.npp.1300329","article-title":"In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum","volume":"29","author":"Navailles","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.112.195156_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0306-4522(99)00011-1","article-title":"Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain","volume":"92","author":"Pasqualetti","year":"1999","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.112.195156_bib38","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"10.1124\/jpet.112.195156_bib39","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.22-22-10039.2002","article-title":"Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice","volume":"22","author":"Rocha","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.112.195156_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0091-3057(99)00049-0","article-title":"Pharmacological and environmental determinants of relapse to cocaine-seeking behavior","volume":"64","author":"Spealman","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.112.195156_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3565(25)20686-3","article-title":"Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior","volume":"251","author":"Spealman","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.195156_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.112.195156_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/syn.20645","article-title":"Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats","volume":"63","author":"Zaniewska","year":"2009","journal-title":"Synapse"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524183279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524183279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.195156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:10:55Z","timestamp":1739985055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524183279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0022356524183279"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.195156","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Serotonin 2C Receptor Antagonist SB 242084 Exhibits Abuse-Related Effects Typical of Stimulants in Squirrel Monkeys","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.195156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}